SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-056524
Filing Date
2015-08-05
Accepted
2015-08-05 16:30:42
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-12160_110q.htm 10-Q 957621
2 EX-31.1 a15-12160_1ex31d1.htm EX-31.1 12151
3 EX-31.2 a15-12160_1ex31d2.htm EX-31.2 11769
4 EX-32.1 a15-12160_1ex32d1.htm EX-32.1 7057
5 EX-32.2 a15-12160_1ex32d2.htm EX-32.2 7038
  Complete submission text file 0001104659-15-056524.txt   3999875

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT loxo-20150630.xml EX-101.INS 875356
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT loxo-20150630.xsd EX-101.SCH 28516
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT loxo-20150630_cal.xml EX-101.CAL 26409
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT loxo-20150630_def.xml EX-101.DEF 105118
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT loxo-20150630_lab.xml EX-101.LAB 298735
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT loxo-20150630_pre.xml EX-101.PRE 204640
Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36562 | Film No.: 151029389
SIC: 2834 Pharmaceutical Preparations